EPS for Invacare Corporation (IVC) Expected At $-0.42

January 13, 2018 - By Adrian Erickson

 EPS for Invacare Corporation (IVC) Expected At $ 0.42
Investors sentiment decreased to 1.63 in 2017 Q3. Its down 0.31, from 1.94 in 2017Q2. It dropped, as 11 investors sold Invacare Corporation shares while 29 reduced holdings. 12 funds opened positions while 53 raised stakes. 42.33 million shares or 11.81% more from 37.86 million shares in 2017Q2 were reported.
14,369 are held by Ngam Limited Partnership. Barclays Public Ltd Com accumulated 0% or 808 shares. Advisory Services Net stated it has 0% in Invacare Corporation (NYSE:IVC). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 422 shares. Int Gru stated it has 25,305 shares or 0% of all its holdings. Public Employees Retirement Association Of Colorado accumulated 7,352 shares. Moreover, Axa has 0% invested in Invacare Corporation (NYSE:IVC) for 13,500 shares. 1.28 million were reported by Brandes Invest Ptnrs L P. Principal Gp holds 0% in Invacare Corporation (NYSE:IVC) or 258,442 shares. Pinebridge Investments Ltd Partnership has invested 0.02% of its portfolio in Invacare Corporation (NYSE:IVC). Employees Retirement Of Ohio accumulated 0% or 8,151 shares. Tiaa Cref Investment Ltd Llc reported 0% stake. California Pub Employees Retirement Sys holds 154,603 shares or 0% of its portfolio. Boston Prns accumulated 0% or 158,290 shares. Dimensional Fund Advsrs L P reported 0.02% in Invacare Corporation (NYSE:IVC).

Since September 13, 2017, it had 0 buys, and 1 insider sale for $94,697 activity.

Analysts expect Invacare Corporation (NYSE:IVC) to report $-0.42 EPS on February, 8.They anticipate $0.04 EPS change or 8.70 % from last quarter’s $-0.46 EPS. After having $-0.41 EPS previously, Invacare Corporation’s analysts see 2.44 % EPS growth. The stock increased 1.49% or $0.25 during the last trading session, reaching $17.05. About 283,466 shares traded. Invacare Corporation (NYSE:IVC) has risen 42.93% since January 13, 2017 and is uptrending. It has outperformed by 26.23% the S&P500.

Invacare Corporation (NYSE:IVC) Ratings Coverage

Among 2 analysts covering Invacare Corporation (NYSE:IVC), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invacare Corporation had 3 analyst reports since April 5, 2017 according to SRatingsIntel. The stock of Invacare Corporation (NYSE:IVC) earned “Buy” rating by KeyBanc Capital Markets on Tuesday, September 26. The rating was maintained by Stephens on Wednesday, April 5 with “Equal Weight”. Stephens upgraded the shares of IVC in report on Monday, May 1 to “Overweight” rating.

Invacare Corporation, together with its subsidiaries, designs, makes, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company has market cap of $559.86 million. The firm operates through four divisions: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific. It currently has negative earnings. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: